Genetic factors in cardiac hypertrophy

被引：18

作者：

Dorn, GW ^{[1
]}

Hahn, HS ^{[1
]}

机构：

[1] Univ Cincinnati, Med Ctr, Heart & Vasc Ctr, Cincinnati, OH 45267 USA

来源：

CARDIAC ENGINEERING: FROM GENES AND CELLS TO STRUCTURE AND FUNCTION | 2004年 / 1015卷

关键词：

heart failure; receptor signaling; myocardial hypertrophy;

D O I：

10.1196/annals.1302.019

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Cardiac hypertrophy is an adaptive response to any cardiac insult or stress that increases hemodynamic load. Cardiac hypertrophy can exist in a state of compensation or progress to a decompensated state (i.e., heart failure) over time. It has been established through transgenic overexpression and gene ablation studies that multiple signaling pathways are involved in the induction of hypertrophy as well as its decompensation. This article reviews the role of Galphaq in the development of pressure overload hypertrophy and discusses the relationships between Galphaq and beta-adrenergic receptors, RGS proteins, and the proapoptotic factor, Nix/Bnip3L.

引用

页码：225 / 237

页数：13

共 82 条

[1] Prostaglandin F-2 alpha stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes [J].

Adams, JW ;

Migita, DS ;

Yu, MK ;

Young, R ;

Hellickson, MS ;

CastroVargas, FE ;

Domingo, JD ;

Lee, PH ;

Bui, JS ;

Henderson, SA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :1179-1186

[2] Enhanced Gαq signaling:: A common pathway mediates cardiac hypertrophy and apoptotic heart failure [J].

Adams, JW ;

Sakata, Y ;

Davis, MG ;

Sah, VP ;

Wang, YB ;

Liggett, SB ;

Chien, KR ;

Brown, JH ;

Dorn, GW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :10140-10145

[3] Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy [J].

Akhter, SA ;

Luttrell, LM ;

Rockman, HA ;

Iaccarino, G ;

Lefkowitz, RJ ;

Koch, WJ .

SCIENCE, 1998, 280 (5363) :574-577

[4] Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy [J].

Aronow, BJ ;

Toyokawa, T ;

Canning, A ;

Haghighi, K ;

Delling, U ;

Kranias, E ;

Molkentin, JD ;

Dorn, GW .

PHYSIOLOGICAL GENOMICS, 2001, 6 (01) :19-28

[5] RENIN-ANGIOTENSIN SYSTEM INVOLVEMENT IN PRESSURE-OVERLOAD CARDIAC-HYPERTROPHY IN RATS [J].

BAKER, KM ;

CHERNIN, MI ;

WIXSON, SK ;

ACETO, JF .

AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (02) :H324-H332

[6] REGIONAL CARDIAC PROSTAGLANDIN RELEASE DURING MYOCARDIAL ISCHEMIA IN ANESTHETIZED DOGS [J].

BERGER, HJ ;

ZARET, BL ;

SPEROFF, L ;

COHEN, LS ;

WOLFSON, S .

CIRCULATION RESEARCH, 1976, 38 (06) :566-571

[7] The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes [J].

Bialik, S ;

Cryns, VL ;

Drincic, A ;

Miyata, S ;

Wollowick, AL ;

Srinivasan, A ;

Kitsis, RN .

CIRCULATION RESEARCH, 1999, 85 (05) :403-414

[8] Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart [J].

Bowling, N ;

Walsh, RA ;

Song, GJ ;

Estridge, T ;

Sandusky, GE ;

Fouts, RL ;

Mintze, K ;

Pickard, T ;

Roden, R ;

Bristow, MR ;

Sabbah, HN ;

Mizrahi, JL ;

Gromo, G ;

King, GL ;

Vlahos, CJ .

CIRCULATION, 1999, 99 (03) :384-391

[9] Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates [J].

Bowman, JC ;

Steinberg, SF ;

Jiang, TR ;

Geenen, DL ;

Fishman, GI ;

Buttrick, PM .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2189-2195

[10] Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins [J].

Chen, G ;

Cizeau, J ;

Velde, CV ;

Park, JH ;

Bozek, G ;

Bolton, J ;

Shi, L ;

Dubik, D ;

Greenberg, A .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (01) :7-10

← 1 2 3 4 5 6 7 8 9 →